ÀÇÎѵ¼º½

The studies’ span speaks to NYU Langone’s strong ability to lead multicenter trials in rheumatology.

Faced with countless unknowns, researchers hunt for therapeutics and vaccines to foil COVID-19.

Researchers investigate clues to help diagnose and treat Parkinson’s disease before symptom onset.

Experts use clinical expertise and basic science research to diagnose a rare autoimmune disorder.

Trial examines hydroxychloroquine’s ability to ward off infections in people exposed to the virus.

Examining resected tumors reveals a lung microbiota signature associated with a poor prognosis.

The host–microbe relationship plays a key role in this stubborn infection.

Dozens of trials explore a wide variety of drug strategies and tumor types.

Trial provides new options for bacillus Calmette-Guérin–unresponsive non-muscle invasive type.

These phase 2 trials provide new options for treating glioblastomas and meningiomas.